Synapse Open Synapse
Biology

STAT+: In China, a flood of controversial clinical trials slows to a trickle

STAT News · · 1 min read

Following patient deaths, China restricts investigator-initiated biotech trials, leaving rare disease families and US investors facing an uncertain future.

Latest from STAT News